13F Data
13F filer · CIK 1032165

FRAZIER MANAGEMENT LLC

SEATTLE, WA · filing since Q4 2015 · last filing Nov 14, 2022
Reported value
$1.1M
$-871.0K vs prior
Positions
1
New / sold out
0 / 1
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $2.1M
Top-10 weight
100.0%

Biggest buys vs Q1 2022

No new or increased positions this quarter.

Biggest sells vs Q1 2022

ChangeSecurityShares changeChange %Est. trade value
ReducedSIERRA ONCOLOGY INC-34,338-62.8%$-1.9M
Sold outALLENA PHARMACEUTICALS-1,019,288-100.0%$-236.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $239.2MQ1 2016: $162.5MQ2 2016: $125.4MQ3 2016: $203.8MQ4 2016: $79.5MQ1 2017: $187.2MQ2 2017: $195.1MQ3 2017: $280.4MQ4 2017: $616.6MQ1 2018: $602.6MQ2 2018: $482.8MQ3 2018: $546.1MQ4 2018: $387.6MQ1 2019: $415.4MQ2 2019: $390.3MQ3 2019: $319.9MQ4 2019: $596.2MQ1 2020: $882.0MQ2 2020: $1.1BQ3 2020: $1.1BQ4 2020: $1.3BQ1 2021: $1.2BQ2 2021: $1.1BQ3 2021: $1.2BQ4 2021: $1.3BQ1 2022: $2.0MQ2 2022: $1.1MQ3 2022: $0
Q4 2015Q3 2022

Holdings · Q2 2022

#SecuritySharesValueWeight
1SIERRA ONCOLOGY INCCOM NEW20,316$1.1M100.00%